Blend Labs, Inc. (NYSE: BLND) is a Technology company in the Software - Application industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | -0.10 | Insider Own | 15.27% | Shs Outstand | 242.12M | Perf Week | 11.17% |
| Market Cap | 481.81M | Forward P/E | 19.51 | EPS next Y | 0.10 | Insider Trans | 21.19% | Shs Float | 171.34M | Perf Month | 8.74% |
| Enterprise Value | 585.81M | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 7.52% | Perf Quarter | 30.07% |
| Income | -5.00M | P/S | 3.76 | EPS this Y | 154.00% | Inst Trans | - | Short Ratio | 3.84 | Perf Half Y | -16.39% |
| Sales | 128.00M | P/B | - | EPS next Y | 88.89% | ROA | -3.49% | Short Interest | 12.89M | Perf YTD | -34.54% |
| Book/sh | -0.23 | P/C | 7.90 | EPS next 5Y | 61.02% | ROE | -12.24% | 52W High | 4.49 -55.68% | Perf Year | -44.10% |
| Cash/sh | 0.25 | P/FCF | - | EPS past 3/5Y | - | ROIC | -0.95% | 52W Low | 1.18 68.64% | Perf 3Y | 51.91% |
| Dividend Est. | - | EV/EBITDA | 146.45 | Sales past 3/5Y | -19.19% 5.25% | Gross Margin | 74.87% | Volatility | 5.86% 6.01% | Perf 5Y | -88.29% |
| Dividend TTM | - | EV/Sales | 4.58 | EPS Y/Y TTM | 58.33% | Oper. Margin | -14.42% | ATR (14) | 0.11 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.78 | Sales Y/Y TTM | -20.99% | Profit Margin | -4.40% | RSI (14) | 64.65 | Recom | 2.42 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.78 | EPS Q/Q | - | SMA20 | 11.80% | Beta | 1.13 | Target Price | 3.33 |
| Payout | 0.00% | Debt/Eq | 5.37 | Sales Q/Q | 14.81% | SMA50 | 15.43% | Rel Volume | 0.62 | Prev Close | 1.93 |
| Employees | 419 | LT Debt/Eq | -5.16 | Earnings | Aug 06 | SMA200 | -9.44% | Avg Volume | 3.22M | Price | 1.99 |
| IPO Date | Jul 16, 2021 | Option/Short | No / Yes | EPS/Sales Surpr. | -1350.00% 2.73% | Net Debt/EBITDA | 28.64 | Volume | 2,004,365 | Change | 3.11% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| May-15-26 | Reiterated | Canaccord Genuity | Buy | $5.25 → $4.50 |
| May-08-26 | Reiterated | Goldman Sachs | Buy | $4.00 → $3.50 |
| Mar-11-26 | Reiterated | UBS | Neutral | $2.00 |
| Feb-28-25 | Reiterated | Canaccord Genuity | Buy | $4.75 → $5.25 |
| Aug-12-24 | Upgrade | Canaccord Genuity | Hold → Buy | $3.00 → $4.75 |
| Aug-09-24 | Upgrade | William Blair | Market Perform → Outperform | |
| Dec-20-23 | Upgrade | Wells Fargo | Equal Weight → Overweight | |
| Nov-14-22 | Upgrade | Keefe, Bruyette & Woods | Underperform → Market Perform | |
| Nov-14-22 | Reiterated | Canaccord Genuity | Hold | $3.00 |
| Jul-25-22 | Downgrade | Keefe, Bruyette & Woods | Market Perform → Underperform |
Established in 2012 and headquartered in San Francisco, California, Blend Labs, Inc. provides cloud-hosted software platforms tailored for financial institutions across the United States. The company's operations are divided into two key divisions: Blend Platform and Title365. It offers a wide array of white-label solutions catering to diverse consumer financial needs, such as home mortgages, home equity loans and lines of credit, vehicle financing, personal loans, credit cards, and deposit account management. Additionally, Blend Labs supplies a specialized suite of tools designed to streamline the entire homeownership process for individuals, covering aspects like loan closing, income validation for mortgages, property insurance, and real estate services. The firm also conducts title examination processes for insurance policies, manages escrow, handles closing and settlement services, and performs various trustee duties, alongside delivering expert professional and advisory services. Its clientele encompasses a broad spectrum of financial entities, including banks, credit unions, financial technology firms, and independent mortgage providers.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 128 | 124 | 162 | 157 | 235 | 234 | 96 | 51 | |
| Cost of Goods Sold Incl. D&A | 31 | 32 | 71 | 76 | 146 | 119 | 34 | 20 | |
| Gross Profit | 94 | 91 | 91 | 81 | 90 | 116 | 62 | 31 | |
| Selling, General and Administrative Excl. Other | 79 | 79 | 87 | 131 | 224 | 213 | 82 | 64 | |
| Research and Development | 34 | 33 | 46 | 82 | 138 | 92 | 56 | 49 | |
| Other Operating Expense | 1 | 0 | 7 | 24 | 474 | 8 | -1 | 0 | |
| Operating Income | -18 | -21 | -50 | -156 | -746 | -197 | -75 | -82 | |
| Interest Expense | 0 | 0 | 7 | 31 | 25 | 11 | 0 | 0 | |
| Unusual Expense | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 18 | 20 | 13 | 7 | 5 | 0 | 1 | 0 | |
| Net Income Before Taxes | 0 | -1 | -43 | -180 | -766 | -208 | -75 | -81 | |
| Income Taxes | 0 | 0 | 0 | 0 | -2 | -39 | 0 | 0 | |
| Consolidated Net Income | -5 | -8 | -50 | -185 | -769 | -171 | -75 | -81 | |
| Net Income From Continuing Operations | 0 | -1 | -43 | -180 | -764 | -169 | -75 | -81 | |
| Net Income | -5 | -8 | -50 | -185 | -769 | -171 | -75 | -81 | |
| EPS (Recurring) | -0.09 | -0.10 | -0.24 | -0.76 | -3.28 | -0.74 | -0.34 | -0.37 | |
| EPS (Basic, Before Extraordinaries) | -0.09 | -0.10 | -0.24 | -0.76 | -3.28 | -0.74 | -0.34 | -0.37 | |
| EPS (Diluted) | -0.10 | -0.10 | -0.24 | -0.76 | -3.28 | -0.74 | -0.34 | -0.37 | |
| EBITDA | 4 | 3 | -32 | -143 | -727 | -183 | -68 | -77 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.98 | 6.35 | 6.60 | 3.98 | 1.43 | 7.21 | — | — | |
| Gross Margin | 73.44 | 73.39 | 56.17 | 51.59 | 38.30 | 49.57 | 64.58 | 60.78 | |
| Operating Margin | -14.06 | -16.94 | -30.86 | -99.36 | -317.45 | -84.19 | -78.13 | -160.78 | |
| Net Margin | -3.91 | -6.45 | -30.86 | -117.83 | -327.23 | -73.08 | -78.13 | -158.82 | |
| Shares Outstanding | 256 | 259 | 254 | 245 | 234 | 230 | 220 | 220 | |
| Market Capitalization | 509 | 787 | 1,069 | 625 | 337 | 1,688 | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Haveli Investments, L.P. | director, 10 percent owner: | Jun 15 '26 | Buy | 1.72 | 650,000 | 1,120,080 | 18,693,657 | Jun 15 |
| Haveli Investments, L.P. | director, 10 percent owner: | Jun 12 '26 | Buy | 1.70 | 256,928 | 436,161 | 18,043,657 | Jun 15 |
| Lantz Erin N | Director | Jun 11 '26 | Option Exercise | 0.00 | 50,000 | 0 | 137,760 | Jun 15 |
| Haveli Investments, L.P. | director, 10 percent owner: | Jun 11 '26 | Buy | 1.74 | 250,000 | 435,125 | 17,786,729 | Jun 15 |
| Woersching Eric H. | Director | Jun 11 '26 | Option Exercise | 0.00 | 50,000 | 0 | 80,000 | Jun 15 |
| Sullivan Bryan Edmund | Director | Jun 11 '26 | Option Exercise | 0.00 | 50,000 | 0 | 100,000 | Jun 15 |
| Chen Gerald C. | Director | Jun 11 '26 | Option Exercise | 0.00 | 50,000 | 0 | 137,760 | Jun 15 |
| Mayopoulos Timothy J | Director | Jun 11 '26 | Option Exercise | 0.00 | 50,000 | 0 | 431,130 | Jun 15 |
| Haveli Investments, L.P. | director, 10 percent owner: | Jun 10 '26 | Buy | 1.67 | 723,460 | 1,210,349 | 17,536,729 | Jun 10 |
| Haveli Investments, L.P. | director, 10 percent owner: | Jun 09 '26 | Buy | 1.70 | 178,677 | 303,876 | 16,813,269 | Jun 10 |
| Haveli Investments, L.P. | director, 10 percent owner: | Jun 08 '26 | Buy | 1.70 | 216,798 | 368,166 | 16,634,592 | Jun 10 |
| Haveli Investments, L.P. | director, 10 percent owner: | Jun 05 '26 | Buy | 1.60 | 28,299 | 45,278 | 16,417,794 | Jun 05 |
| Haveli Investments, L.P. | director, 10 percent owner: | Jun 03 '26 | Buy | 1.56 | 240,307 | 376,056 | 16,389,495 | Jun 05 |
| Haveli Investments, L.P. | director, 10 percent owner: | May 27 '26 | Buy | 1.49 | 1,600 | 2,391 | 16,149,188 | May 27 |
| Haveli Investments, L.P. | director, 10 percent owner: | May 26 '26 | Buy | 1.46 | 243,805 | 355,736 | 16,147,588 | May 27 |